
US lawmakers launch investigation into FDA approval and price of new Alzheimer's drug
CNN
Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm.
The US Food and Drug Administration approved the drug earlier this month under its "accelerated approval" program, although an FDA advisory committee concluded last year that there was not enough evidence to support the effectiveness of the treatment.
Janet Mills and her allies are counting on a gender gap to narrow Platner’s wide lead ahead of the June 9 primary to decide who will face incumbent Republican Sen. Susan Collins. They are betting that the unfiltered style that has brought Platner widespread attention as someone who could help Democrats reach young men will backfire with women.

As a shrinking number of Transportation Security Administration agents work to keep hourslong security lines moving despite not being paid, President Donald Trump stepped into the fray Saturday, announcing he will send Immigration and Customs Enforcement officers to airports by Monday if Congress doesn’t agree to a plan to end the partial government shutdown.











